Fortress Biotech, Inc. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 15, 2016

Attached files

file	filename
10-K - FORM 10-K - Fortress Biotech, Inc.	v432923_10k.htm
EX-23.1 - EXHIBIT 23.1 - Fortress Biotech, Inc.	v432923_ex23-1.htm
EX-32.1 - EXHIBIT 32.1 - Fortress Biotech, Inc.	v432923_ex32-1.htm
EX-23.2 - EXHIBIT 23.2 - Fortress Biotech, Inc.	v432923_ex23-2.htm
EX-99.1 - EXHIBIT 99.1 - Fortress Biotech, Inc.	v432923_ex99-1.htm
EX-32.2 - EXHIBIT 32.2 - Fortress Biotech, Inc.	v432923_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - Fortress Biotech, Inc.	v432923_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - Fortress Biotech, Inc.	v432923_ex31-2.htm

EXHIBIT 21.1

SUBSIDIARIES OF FORTRESS BIOTECH, INC.

Subsidiaries of Fortress Biotech, Inc. at December 31, 2015:

	•	Avenue Therapeutics, Inc.
	•	CB Securities Corporation
	•	Checkpoint Therapeutics, Inc.
	•	Coronado SO Co.
	•	Cyprium, Inc.
	•	Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc.
	•	Helocyte, Inc., formerly DiaVax Biosciences, Inc.
	•	Innmune Limited
	•	Journey Medical Corporation
	•	Mustang Bio, Inc.